Overview

Incretin Effect on the Immunological Phenotype

Status:
Completed

Trial end date:
2015-02-01

Target enrollment:

Participant gender:

Summary

Assessment of the effect of incretin based therapies (Liraglutide and Saxagliptin) on immune cells in healthy subjects and patients with type 1 diabetes

Phase:

Phase 2

Details

Lead Sponsor:

Medical University of Graz

Treatments:

Incretins
Liraglutide
Saxagliptin